DIGITEYES
DEAD

Serial Number

79331433

Owner

Optimo Medical AG

Filing Date

Nov 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

DIGITEYES Trademark

Serial Number: 79331433

DIGITEYES is a trademark filed by Optimo Medical AG on November 3, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Optimo Medical AG

Robert-Walser-Platz 7

Entity Type: 25

Trademark Details

Filing Date

November 3, 2021

Registration Date

Not Registered

Goods & Services

Medical services; veterinary services, animal healthcare services; all the aforementioned in the field of biomechanical simulations or refractive and therapeutic eye surgery; beauty care for humans

Software for the planning and patient-specific prognosis of surgical procedures; software for virtual simulation of biomechanical processes and surgical procedures relating to the human body and more specifically the eyes; mobile software applications for viewing and storing data; software for use in stationary (desktop PC), portable and mobile apparatus; interactive software for digitizing and representing biomechanical processes and surgical procedures for patient education and information as well as for obtaining a second opinion; software for measuring body parts, especially eyes and ophthalmological values; software for virtualizing body parts and surgical planning

Provision of access to computer networks, Internet platforms, databases and electronic publications (local or cloud) for personal planning and patient-specific prognosis for surgical procedures, as well as for the virtual simulation of biomechanical processes associated with the human body and eyes

Financial services, namely, financial modeling of payment and cost structures for hospitals, clinics and patients, installing patient payment systems and creating financial models for clinics

Company management; business management, namely, developing and producing reference value models and improvement options for processes, products and services

Platform as a service (PaaS); computer software as a service (SaaS), namely, maintaining and providing software for use by others for training and teaching specific surgical methods for eyes and intraocular lenses or contact lenses, as well as viewing and storing (local or cloud) the related application, patient-specific data saving and protection as well as processing, in particular, but not limited to, digital twins in the field of medical applications, scientific and technological services on specific computers (desktop PCs) and mobile apparatus with or without integrated artificial intelligence and deep learning algorithms

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 29, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 9, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 10, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 21, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 20, 2023 OPNS
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 10, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 9, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 9, 2023 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2022 NREP
REFUSAL PROCESSED BY IB
Oct 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 22, 2022 RFCS
REFUSAL PROCESSED BY MPU
Sep 22, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 24, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 23, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
May 22, 2022 NREP
APPLICATION FILING RECEIPT MAILED
Jan 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 20, 2022 REPR